Robert A Norman Do Pa

CLIA Laboratory Citation Details

3
Total Citations
12
Total Deficiencyies
10
Unique D-Tags
CMS Certification Number 10D0908280
Address 10820 Sheldon Rd, Tampa, FL, 33626
City Tampa
State FL
Zip Code33626
Phone(813) 880-7546

Citation History (3 surveys)

Survey - October 14, 2025

Survey Type: Standard

Survey Event ID: 2TLY11

Deficiency Tags: D6168 D0000 D6171

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Robert A Norman DO PA on 10/14/2025. The laboratory is not in compliance with 42 CFR Part 493, Requirement for Laboratories. The following Condition was cited: D6168 493.1495 Condition: Laboratory Testing Personnel. D6168 TESTING PERSONNEL CFR(s): 493.1487 The laboratory has a sufficient number of individuals who meet the qualification requirements of 493.1489 of this subpart to perform the functions specified in 493. 1495 of this subpart for the volume and complexity of testing performed. This CONDITION is not met as evidenced by: Based on record review and interview, the laboratory failed to ensure one (#A) of two (#A, #B) testing personnel were qualified to perform testing for the subspecialty of Histopathology from 12/2023 through 10/2025. (See D6171) D6171 TESTING PERSONNEL QUALIFICATIONS CFR(s): 493.1489(b) (b) Meet one of the following requirements: (b)(1) Be a doctor of medicine, doctor of osteopathy, or doctor of podiatric medicine licensed to practice medicine, osteopathy, or podiatry in the State in which the laboratory is located; or (b)(2)(i) Have earned a doctoral, master's, or bachelor's degree in a chemical, biological, clinical or medical laboratory science, or medical technology from an accredited institution; or (b)(2)(ii) Be qualified under the requirements of 493.1443(b)(3) or 493.1449(c)(4) or (5); or (b)(3)(i) Have earned an associate degree in a laboratory science or medical laboratory technology from an accredited institution or (b)(3)(ii) Have education and training equivalent to that specified in paragraph (b)(2)(i) of this section that includes (b)(3)(ii) (A) At least 60 semester hours, or equivalent, from an accredited institution that, at a Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- minimum, includes either (b)(3)(ii)(A)(1) 24 semester hours of medical laboratory technology courses; or (b)(3)(ii)(A)(2) 24 semester hours of science courses that include (b)(3)(ii)(A)(2)(i) 6 semester hours of chemistry; (b)(3)(ii)(A)(2)(ii) 6 semester hours of biology; and (b)(3)(ii)(A)(2)(iii) 12 semester hours of chemistry, biology, or medical laboratory technology in any combination; and (b)(3)(ii)(B) Have laboratory training that includes: (b)(3)(ii)(B)(1) Completion of a clinical laboratory training program approved or accredited by the ABHES or the CAAHEP (this training may be included in the 60 semester hours listed in paragraph (b)(3)(ii)(A) of this section); or (b)(3)(ii)(B)(2) At least 3 months documented laboratory training in each specialty in which the individual performs high complexity testing; or (b)(4) Successful completion of an official U.S. military medical laboratory procedures training course of at least 50 weeks duration and having held the military enlisted occupational specialty of Medical Laboratory Specialist (Laboratory Technician); or (b)(5) Notwithstanding any other provision of this section, an individual is considered qualified as a high complexity testing personnel under this section if they were qualified and serving as a high complexity testing personnel in a CLIA-certified laboratory as of December 28, 2024, and have done so continuously since December 28, 2024. (b)(6) For blood gas analysis (b)(6)(i) Be qualified under paragraph (b)(1), (2), (3), (4), or (5) of this section; or (b)(6)(ii) Have earned a bachelor's degree in respiratory therapy or cardiovascular technology from an accredited institution; or (b) (6)(iii) Have earned an associate degree related to pulmonary function from an accredited institution. (b)(7) For histopathology, meet the qualifications of 493.1449 (b) or (f) to perform tissue examinations. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to ensure one testing personnel (#A) of two testing personnel (#A, #B) met the qualifications for performing testing in the subspecialty of Histopathology from 12/2023 through 10 /2025. Findings included: 1. The Form CMS-209 Laboratory Personnel Report (CLIA), signed by the Laboratory Director on 10/14/2025 was reviewed. Testing personnel (TP) #A was documented as high complexity testing personnel. 2. Documentation of education was reviewed. TP #A had a Bachelor of Arts degree. TP #A's transcript was reviewed. The transcript documented TP #A's degree was a Bachelor of Arts with a Major in Psychology. 10 hours of biology and 3 hours of chemistry were documented as completed. TP #A was short 3 hours of chemistry and 8 hours of additional classes in either chemistry, biology, or medical laboratory technology. 3. An annual competency evaluation for TP #A, signed by the Laboratory Director 01/05/2024 and 01/03/2025, showed TP #A was evaluated for grossing of patient tissue. 4. An interview with TP #A and the Laboratory Director on 10/21/2025 at approximately 12:00 p.m. confirmed TP #A performed grossing of patient specimens (high complexity testing). All data the laboratory had was provided to represent TP #A's qualifications. 5. Review of the Form CMS-116, Application for Certification for a survey, signed by the Laboratory Director on 10/14/2025 documented an annual test volume of 648 patient tests for the subspecialty of Histopathology. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 13, 2023

Survey Type: Standard

Survey Event ID: VOBO11

Deficiency Tags: D0000 D5805

Summary:

Summary Statement of Deficiencies D0000 An on-site announced CLIA recertification survey was conducted at Robert A Norman DO PA on 10/13/2023. The laboratory is not in compliance with 42 CFR Part 493, Requirements for Laboratories. The following is a description of the standard level deficiencies: D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on record review and interview with the Laboratory Director, the laboratory failed to specify where the technical (grossing and slide preparation) component for histopathology testing was performed on 4 out of 4 (#1, #2, #3 and #4) patient histopathology reports reviewed. Findings Included: Review of final histopathology reports for Patient #1 - electronically signed 1/27/22, Patient #2 - 07/05/22, Patient #3 - 02/16/23, and Patient #4 - 08/09/23 revealed the final report failed to include where the technical component had been performed. On 10/13/23 at 11:30 AM, the Lab Director confirmed the histopathology reports did not specify the technical component location. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 2, 2019

Survey Type: Standard

Survey Event ID: HUD211

Deficiency Tags: D0000 D5403 D6078 D6117 D5391 D6076 D6103

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Robert A Norman DO PA on 07/02/2019. The laboratory is not in compliance with 42 CFR Part 493, Requirement for Laboratories. The following Condition was cited: D6076 - 42 C.F.R. 493.1441: Laboratories performing high complexity testing; laboratory director D5391 PREANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1249(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems specified at 493.1241 through 493.1242. This STANDARD is not met as evidenced by: Based on record review and interview with Dermatopathologist, the laboratory failed to have a written preanalytic quality assessment policy. Findings include: Review of the procedure manual revealed no preanalytic quality assessment procedure was present to monitor, assess, and correct problems identified with preanalytic systems. Interview on 07/02/19 at 12:15 PM with the Dermatopathologist revealed she did now know the laboratory was without a preanalytic quality assessment procedure and confirmed that quality assessment procedures were not being documented. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access